As a consequence, the β1 precursor accumulates in the ER, and the mutant α3 precursor is cleared by ubiquitination and degradation by the proteasome.
We have identified a gain-of-glycosylation mutation in ITGA3 that prevents the biosynthesis of functional α3β1, leading to severe kidney and lung defects.